Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2019 | International Symposium on Acute Leukemias: key messages from the 2019 meeting

Wolfgang Hiddemann • 15 Mar 2019
ISAL 2019
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Leukemia

Chair of the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany, Wolfgang Hiddemann, MD, PhD, of LMU Hospital Munich, Munich, Germany, discusses the highlights of this year’s meeting, with many updates, particularly in acute myeloid leukemia, since the last meeting in 2017.

Explore the AML Channel banner with headshots of Naval Daver, Eunice Wang, and Thomas Cluzeau

More from Wolfgang Hiddemann

ISAL 2023: looking forward to this year's meeting and insights into the program
3:08
ISAL 2023: looking forward to this year's meeting and insights into the program
Wolfgang Hiddemann • 16 Mar 2023
Acute leukemia research at LMU Munich
1:04
Acute leukemia research at LMU Munich
Wolfgang Hiddemann • 14 Mar 2019
Challenging the norms for elderly AML treatment: clinical trials & intensive therapy
8:26
Challenging the norms for elderly AML treatment: clinical trials & intensive therapy
Alan Burnett et al. • 17 Feb 2018
Optimization of standard AML treatment: APL advances, adverse cytogenetics & post-remission therapy
11:35
Optimization of standard AML treatment: APL advances, adverse cytogenetics & post-remission therapy
Alan Burnett et al. • 2 Mar 2018

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals